Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adults

Last updated: November 6, 2024
Sponsor: University Hospital Tuebingen
Overall Status: Active - Recruiting

Phase

N/A

Condition

Melanoma

Treatment

N/A

Clinical Study ID

NCT06680323
834/2023BO2
  • Ages < 30
  • All Genders

Study Summary

The primary objective of this study is the identification of environmental and genetic factors involved in the risk and progression of melanoma in children, adolescents and young adults (CAYA). The secondary objectives are to generate a model integrating the genetic and environmental factors to estimate the risk of developing melanoma and improve the primary prevention of melanoma through evidence-based interpretation of environmental risk.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • confirmed melanoma

  • age until 30 years old

Exclusion

Exclusion Criteria:

  • no available biological material

  • no signed informed consent

Study Design

Total Participants: 200
Study Start date:
January 01, 2024
Estimated Completion Date:
May 31, 2026

Study Description

By retrieving data from several epidemiological and clinical registries across Europe it is aimed to integrate and maximize efforts in order to create a large dataset that serves for a comprehensive analysis of genetic and environmental factors influencing the etiology of melanoma in CAYA. The data will be combined with exposome information about climate and pollution for the development of a weighted risk score. Furthermore, germline high risk mutations and germline low-medium risk variants will be analyzed. Genome and transcriptome sequencing of blood and in selected cases tumour will provide the most comprehensive data to create a polygenic risk score for CAYA melanoma. Transcriptome data will help to identify and characterize the effect of variants of unknown significance in coding, intronic as well as regulatory regions. Tumour sequencing can provide additional information on functional relevance of variants, e.g. secondary hits in tumour tissue or second hits in tumour suppressor genes. Such identification will be highly advantageous to design prevention strategies for melanoma development in CAYA.

Connect with a study center

  • Leibniz Research Institute for Environmental Medicine

    Düsseldorf, 40225
    Germany

    Site Not Available

  • University of Florence

    Florence, 50121
    Italy

    Site Not Available

  • Istituto Nazionale del Tumori

    Milan, 20133
    Italy

    Site Not Available

  • Medical University of Gdánsk

    Gdańsk, 80-210
    Poland

    Active - Recruiting

  • Hospital Clínic de Barcelona

    Barcelona, 08036
    Spain

    Active - Recruiting

  • Karolinska Institute

    Solna, 17177
    Sweden

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.